References
Vere, DW. Drug adverse reactions as masquereders. Adverse Drug Reaction Bull. 1976;60:208–211.
Ahmed, M, Davison, OW. Severe cystitis associated with tiaprofenic acid. Br Med, J. 1991;303:1376.
Ghose, K. Cystitis and nonsteroidal antiinflammatory drugs: an incidental association or an adverse effect? New Zealand Med, J. 1993;106:501–503.
Greene, GF, Millard, OH, Norman, RW, Boudreau, SF, Auld, RB, Awad, SA. Cystitis associated with tiaprofenic acid. J Urol. 1994;152:1101–1102.
Harrison, WJ, Willis, RG, Neal, DE. Adverse reactions to tiaprofenic acid mimicking interstitial cystitis. Br Med, J. 1994;309:574.
O’Neil, GF. Tiaprofenic acid as a cause of non-bacterial cystitis. Med J Australia. 1994;160:123–125.
Anon. Severe cystitis with tiaprofenic acid (Surgam). Current Prob. 1994;21:11.
Terol, MJ, Cervantes, F, Pereira, A, Rozman, C. Autoimmune hemolytic anaemia after 9 years of treatment with alphmethyldopa. (letter). Med Clin Bare. 1991:101:598.
McKenzie, R, Fried, MW, Sallie, R, Conjeevaram, H, Di-Bisceglie, AM, Park, Y, Savarese, B, Kleiner, D, Tsokos, M, Luciano, C, et al. Hepatic failure and lactic acidosis due to fialuridine (FLAU), an investigational nucleoside analogue for chronic hepatitis, B. N Engl J Med. 1995;333(17):1099–1105.
Pepys, J, Pepys, EO, Baldo, BA, Whitwam, JG. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthetic. 1994;49:470–475.
Stephens, M. Deliberate drug rechallenge. Hum Toxicol. 1983;2(4):573–577.
Smith, PM, Wilton, A, Routledge, PA. Case report. Jaundice associated with amoxycillin—clavulonate potassium therapy. Eur J Gastroenterol Hepatol. 1991;3:95–96.
Miros, M, Kerlin, P, Walker, N, Harris, O. Flucloxacillin induced delayed cholestatic hepatitis. Aust New Zealand J Med. 1990;20:251–253.
Davies, MH, Harrison, RF, Elias, E, Hubscher, SG. Antibiotic-associated acute vanishing bile duct syndrome; a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol. 1994;20:112–116.
Rawlins, MD. Pharmacovigilance: paradise lost, regained or postponed? J Roy Coll Physicians. 1995; 29:41–49.
Bateman, DN, Sanders GLS, Rawlins, MD. Attitudes to adverse drug reaction reporting: The Northern Region. Br J Clin Pharmac. 1992;34:421–426.
Houghton, JE, Pinto Pereira, LM, Woods, FJ, Richens, A, Routledge, PA. The Welsh Adverse Drug Reactions Scheme; experience of a UK regional monitoring centre. Adverse Drug Reac Toxicol Rev. 1996; 15(2).
Albengres, E, Gauthier, F, Tillement, JP. Current French system of post-marketing drug surveillance. Int J Clin Pharmacol Ther Toxicol. 1990;312–314.
Begaud, B, Chaslerie, A, Haramburu, F. Organization and results of drug vigilance in France. Rev Epidemiol Sante Publique. 1994;42:416–423.
Edwards, IR, Lindquist, M, Wiholm, BE, Napke, E. Quality criteria for early signals of possible adverse drug reactions. Lancet. 1990;336:156–158.
Griffin, JP. Survey of the adverse drug reporting ode-mas in fifteen countries. Br J Clin Pharmacol. 1986; 22:835–1005.
Walker, RS, Linton, AL. Phenethyldiguanide: A dangerous side-effect. Br Med, J. 1959;2:1005–1006.
Chandalia, HB, Rangnath, M. Biguanide induced lactic acidosis. J Ass Physicians India. 1990;38:620–622.
McGuinness, ME, Talbert, RJ. Phenformin-induced lactic acidosis: a forgotten adverse drug reaction. Ann Pharmacother. 1993;27:1183–1187.
Soria-Royer, C, Legendre, C, Mircheva, J, Premel, S, Beaune, P, Kreis, H. Thiopurine-methyl transferase activity to assess azathioprine myeltoxicity in renal transplant recipients (letter). Lancet. 1993;341(8860) 1593–1594.
Evans DAP, Manley, KA, Makusick, VA. Genetic control of isoniazid metabolism in man. Br Med, J. 1960;2:485–491.
Adams, LE, Hess, EV. Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Safety. 1991:6:431–449.
Hutchings, A, Routledge, PA. A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmac. 1986;22:343–345.
Hutchings, A, Routledge, PA. A single sample sauva test to measure acetylator phenotype using isoniazid. Br J Clin Pharmac. 1996;42:635–637.
Bechtel, PR. Relevance and limits of pharmacogenetics to detect patients at risk of adverse drug reactions. Pharmacoepidem Drug Safety. 1995;4:31–36.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Routledge, P.A., Bialas, M.C., Houghton, J.E. et al. Adverse Drug Reactions: The Great Masqueraders. Ther Innov Regul Sci 32, 79–84 (1998). https://doi.org/10.1177/009286159803200111
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286159803200111